AMGEN TO PRESENT AT THE 45TH ANNUAL TD COWEN HEALTH CARE CONFERENCE
Amgen (NASDAQ: AMGN) has announced its participation in the 45th Annual TD Cowen Health Care Conference scheduled for March 5, 2025, at 9:10 a.m. ET. Jay Bradner, executive vice president of Research and Development, will engage in a fireside chat during the conference.
The presentation will be accessible through a live webcast available to investors, media, and the general public. The webcast can be accessed on www.amgen.com under the Investors section, along with other management presentations from investor and medical conferences. The webcast recording will remain available for replay for a minimum of 90 days following the event.
Amgen (NASDAQ: AMGN) ha annunciato la sua partecipazione al 45° Annuale TD Cowen Health Care Conference in programma per il 5 marzo 2025, alle 9:10 a.m. ET. Jay Bradner, vicepresidente esecutivo della Ricerca e Sviluppo, parteciperà a una chiacchierata informale durante la conferenza.
La presentazione sarà accessibile tramite un webcast dal vivo disponibile per investitori, media e il pubblico generale. Il webcast sarà accessibile su www.amgen.com nella sezione Investitori, insieme ad altre presentazioni della direzione provenienti da conferenze per investitori e mediche. La registrazione del webcast rimarrà disponibile per la visione per un minimo di 90 giorni dopo l'evento.
Amgen (NASDAQ: AMGN) ha anunciado su participación en la 45ª Conferencia Anual de Salud TD Cowen, programada para el 5 de marzo de 2025, a las 9:10 a.m. ET. Jay Bradner, vicepresidente ejecutivo de Investigación y Desarrollo, participará en una charla informal durante la conferencia.
La presentación estará disponible a través de un webcast en vivo accesible para inversores, medios de comunicación y el público en general. El webcast se podrá acceder en www.amgen.com en la sección de Inversores, junto con otras presentaciones de la dirección de conferencias para inversores y médicas. La grabación del webcast permanecerá disponible para su reproducción durante un mínimo de 90 días después del evento.
암젠 (NASDAQ: AMGN)은 2025년 3월 5일 오전 9시 10분 ET에 예정된 제45회 연례 TD Cowen 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 제이 브래드너 연구개발 부사장이 컨퍼런스에서 대화형 세션에 참여할 예정입니다.
발표는 투자자, 언론 및 일반 대중이 이용할 수 있는 실시간 웹캐스트를 통해 접근할 수 있습니다. 웹캐스트는 www.amgen.com의 투자자 섹션에서 다른 투자자 및 의료 회의의 경영진 발표와 함께 접근할 수 있습니다. 웹캐스트 녹화는 이벤트 이후 최소 90일 동안 재생할 수 있습니다.
Amgen (NASDAQ: AMGN) a annoncé sa participation à la 45e Conférence Annuelle TD Cowen sur la Santé, prévue pour le 5 mars 2025 à 9h10 ET. Jay Bradner, vice-président exécutif de la Recherche et du Développement, participera à une discussion informelle durant la conférence.
La présentation sera accessible via un webinaire en direct disponible pour les investisseurs, les médias et le grand public. Le webinaire pourra être consulté sur www.amgen.com dans la section Investisseurs, ainsi qu'avec d'autres présentations de la direction provenant de conférences pour investisseurs et médicales. L'enregistrement du webinaire restera disponible en replay pendant un minimum de 90 jours après l'événement.
Amgen (NASDAQ: AMGN) hat seine Teilnahme an der 45. jährlichen TD Cowen Gesundheitskonferenz bekannt gegeben, die für den 5. März 2025 um 9:10 Uhr ET geplant ist. Jay Bradner, Executive Vice President für Forschung und Entwicklung, wird während der Konferenz an einem informellen Gespräch teilnehmen.
Die Präsentation wird über ein Live-Webcast zugänglich sein, das für Investoren, Medien und die allgemeine Öffentlichkeit verfügbar ist. Der Webcast kann auf www.amgen.com im Bereich Investoren abgerufen werden, zusammen mit anderen Präsentationen des Managements von Investoren- und medizinischen Konferenzen. Die Aufzeichnung des Webcasts bleibt mindestens 90 Tage nach der Veranstaltung verfügbar.
- None.
- None.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn, Instagram, YouTube and Threads.
CONTACT: Amgen,
Elissa Snook, 609-251-1407 (media)
Justin Claeys, 805-313-9775 (investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-45th-annual-td-cowen-health-care-conference-302388840.html
SOURCE Amgen
FAQ
When is Amgen (AMGN) presenting at the TD Cowen Health Care Conference 2025?
Who will represent AMGN at the 2025 TD Cowen Health Care Conference?
How can investors watch Amgen's (AMGN) TD Cowen Conference presentation?
How long will AMGN's TD Cowen Conference webcast be available for replay?
